Nurami Medical, a medical device R&D company, which is developing a groundbreaking technology that facilitates post-surgical healing of soft tissue healing, has announced that it has completed a fundraising round of up to $6 million.

 The company is actively developing additional products for healing and regeneration of soft tissues, which represents a $20 billion market.  The company has built a strong advisory board, which includes, amongst others, leading neurosurgeons from around the world.

Nurami Medical Raises Up To $6 Million Round In Series B Funding Led By Almeda Ventures

Description

Company Information

Nurami Medical Raises Up To $6 Million Round In Series B Funding Led By Almeda Ventures

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information